EUVIMEDTutustu EUVIMEDiin
CrossrefTietokortti

Histiocytosis X or Langerhans’ Cell Histiocytosis – Evaluation, Treatment and Prognosis

I. Haas, A. Donner

Oto-Rhino-Laryngologia Nova · 1998

DOI: 10.1159/000027814 ↗
TiivistelmäBibliografiset tiedot

Tiivistelmä

Objectives: The pathology and the extreme clinical varieties of this disease with emphasis on head and neck manifestations are discussed. Material: A case of Langerhans’ cell histiocytosis (LCH) with extensive destruction of temporal bones is presented. Results and Conclusions: LCH or histiocytosis X embraces a group of rare, mainly pediatric disorders of disputable nature. Granulomatous lesions can be detected in one (unifocal) or multiple organs or tissues (multifocal) with extreme clinical variety from self-healing monostotic lesions to multisystemic life-threatening disease. Lesions typically consist of dendritic antigen-presenting Langerhans’ cells, eosinophilic granulocytes, lymphocytes, ordinary histiocytes, foam cells and multinucleated giant cells. No histopathologic criteria exist in regard to prognosis. Unpredictable behavior of LCH also defies a convenient clinical classification, but number of lesions, vital organ involvement and dysfunction seem to be prognostically and thus therapeutically relevant. Although proof of monoclonality indicates a true neoplastic process, no prognostic use results so far since clonality has been detected in all forms of LCH.

Työhösi sopivaa tietoa.

Maksuttomasta aloituksesta ja henkilökohtaisesta kirjallisuushausta koko Research Suite -kokonaisuuteen.

Katso hinnat →

Sisältyvätkö kaikki kustantajien kokotekstit?

Ei. Bibliografiset viitteet, tiivistelmät ja kokotekstit ovat eri sisältöjä. Se, onko kokoteksti saatavilla, riippuu lähteestä, Open Accessista ja olemassa olevista lisensseistäsi. EUVIMED-paketti ei korvaa ylimääräisiä kustantajaoikeuksia.

Katso hinnat →